Asher C. Park

Asher C. Park

Auto-generated profile, based on publicly available information

Asher C. Park

Department of Otolaryngology–Head and Neck Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
DFDavid Jun Fei-Zhang
David Jun Fei-Zhang
APAsher C. Park
Asher C. Park
DCDaniel C. Chelius
Daniel C. Chelius
SSStephanie S. Smith
Stephanie S. Smith
SSSandeep Samant
Sandeep Samant
JRJeffrey C. Rastatter
Jeffrey C. Rastatter
Objective: To investigate the association of social determinants of health (SDoH) in squamous cell carcinoma of the tongue in the United States and to evaluate the real‐world contribution of specific disparities.Study Design: Retrospective cohort study.Setting: United States.Methods: The Centers for Disease Control and Prevention‐Social Vulnerability Index (SVI) and National Cancer Institute‐Surveillance, Epidemiology, and End Results Program database were used to study 62,103 adult tongue squamous cell carcinoma patients from 1975 to 2017. Regression analysis assessed trends in months of follow‐up and survival across social vulnerability and 4 subcategories of social vulnerability.Results: As overall SVI score increases (increased social vulnerability), there is a significant decrease in the average length of follow‐up (22.95% decrease from 63.99 to 49.31 months; P < .001) across patients from the lowest and highest social vulnerability groups. As overall SVI score increases, there is a significant decrease in the average months of survival (28.00% decrease from 49.20 to 35.43 months; P < .001). There is also a significantly greater odds ratio (OR = 1.05; P < .001) of advanced cancer staging upon presentation at higher SVI scores. Patients with higher SVI scores have a lower OR (0.93; P < .001) of receiving surgery as their primary treatment when compared to patients with lower SVI scores. Patients with higher SVI scores also have a significantly greater OR (OR = 1.05; P < .001) of receiving chemotherapy as their primary treatment when compared to patients with lower SVI scores.Conclusion: Increased social vulnerability is shown to have a detrimental impact on the treatment and prognosis of patients with squamous cell carcinoma of the tongue.

21 April 2025 in The Laryngoscope
Verified
Journal Article
Open access
APAsher C. Park
Asher C. Park
LWLarry Wang
Larry Wang
MFMilan P. Fehrenbach
Milan P. Fehrenbach
OAOluwatobiloba Ayo‐Ajibola
Oluwatobiloba Ayo‐Ajibola
UPUrjeet A. Patel
Urjeet A. Patel
KSKatelyn O. Stepan
Katelyn O. Stepan
Objective: Assess associations between non‐tobacco nicotine usage and free flap repair complications in head and neck cancer (HNC) patients.Study Design: Propensity‐matched retrospective cohort study.Methods: The TriNetX database was queried for HNC patients who underwent free flap procedures from 2010 to 2024. Among these patients, the NIC cohort was defined as those with dependence on nicotine prior to surgery, but without the use of cigarettes, chewing tobacco, or other tobacco products. The non‐NIC cohort was defined as patients with no nicotine dependence, cigarettes, chewing tobacco, or other tobacco product use prior to surgery. Cohorts were propensity‐matched based on demographics and comorbidities. Primary outcomes included free flap failure, blood vessel repair, and other revisionary procedures (associated with wound disruption or repair) within 30 days of the primary reconstruction. Secondary outcomes included infection, pneumonia, cardiopulmonary complications, and hematoma within 30 days.Results: Following propensity matching, 1324 patients were included in each cohort. Across all free flaps, non‐tobacco nicotine use was associated with a significantly increased risk of other revision procedures (RR: 1.230 [95% CI: 1.013, 1.493], p = 0.036), sepsis (RR: 1.563 [95% CI: 1.009, 2.419], p = 0.045), fistula (RR: 1.588 [95% CI: 1.041, 2.423], p = 0.032), cardiovascular complications (RR: 1.420 [95% CI: 1.054, 1.914], p = 0.021), pneumonia (RR: 2.055 [95% CI: 1.570, 2.689], p < 0.001), and pulmonary embolism (RR: 2.220 [95% CI: 1.217, 3.933], p = 0.008).Conclusions: Non‐tobacco nicotine use is associated with an increased risk of postoperative complications in HNC patients following free flap reconstruction. Screening for non‐tobacco nicotine use in surgical candidates may better inform clinical management and counseling.Level of Evidence: III

29 January 2026 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
APAsher C. Park
Asher C. Park
BGBrooke N. Gleason
Brooke N. Gleason
ESEli Stein
Eli Stein
SGSaied Ghadersohi
Saied Ghadersohi
AKAtsushi Kato
Atsushi Kato
BTBruce K. Tan
Bruce K. Tan
Background: Appropriate medical therapy (AMT) is first‐line treatment for patients with chronic rhinosinusitis (CRS). We evaluated inflammatory structure, treatment‐induced changes, and biomarker‐outcome associations in AMT‐managed patients. Methods: Fifty‐one CRS patients were evaluated before and after AMT which included a combination of oral antibiotics, oral steroids, or intranasal steroids tailored to CRS phenotype and severity. At each visit, patients completed the SNOT‐22, CRS‐PRO, Brief Smell Identification Test (BSIT), CT scan (Lund–Mackay Score [LM]), and endoscopy (Modified Lund–Kennedy Score [MLK]). Middle‐meatal mucus was analyzed for IL‐1b, IL‐5, IL‐13, IFN‐g, and MIP1a using Luminex and ELISA. Principal components analysis (PCA) was performed on baseline cytokine data to identify key biomarker axes. Paired‐sample Wilcoxon tests compared cytokine changes, and Spearman's correlation assessed relationships between biomarkers and disease measures. Results: PCA revealed two major components: PC‐1 (inflammation severity) dominated by ECP and MIP1a, and PC‐2 (endotype axis) with positive weighting of IL‐5 and IL‐13 (T2) and negative weighting of IFN‐g and IL‐1b (T1/3). AMT significantly reduced inflammatory severity and T2 biomarker burden, driven by decreases in IL‐5, IL‐13, ECP, and MIP1a (all p < 0.01), while T1/3 biomarker remained unchanged. Clinical outcomes, including MLK, SNOT‐22, CRS‐PRO, and BSIT, improved and showed stronger correlations with T2 than T1/3 biomarkers. Conclusion: AMT for CRS is associated with reduction in index biomarkers across inflammatory severity and T2 endotype with minimal effects on T1/3 inflammation. T2‐driven inflammation appears to be the most AMT‐responsive axis found in this study, aligning with measurable improvements in endoscopic, patient reported, and nasal airflow outcomes.

10 June 2023 in The Laryngoscope
Verified
Journal Article
Open access
APAsher C. Park
Asher C. Park
DHDana M. Hutchison
Dana M. Hutchison
KPKarthik R. Prasad
Karthik R. Prasad
KHKelly Hernandez
Kelly Hernandez
KDKatelyn K. Dilley
Katelyn K. Dilley
BWBrian J‐F Wong
Brian J‐F Wong
Handheld ultrasound devices can be used in revision rhinoplasty to evaluate the calcification of costal rib cartilage that is to be harvested for grafting. This article provides instructions on how to perform this technique. Laryngoscope, 2023.

1 October 2024 in OTO Open
Verified
Journal Article
Open access
Shravan AsthanaShravan Asthana
Shravan Asthana
APAsher C. Park
Asher C. Park
ATAbhinav Talwar
Abhinav Talwar
KBKirsten B. Burdett
Kirsten B. Burdett
CPChristopher Puchi
Christopher Puchi
KSKatelyn O. Stepan
Katelyn O. Stepan
Objective: To characterize neighborhood‐level area deprivation's association with oropharyngeal carcinoma clinicodemographics, tumor staging, recurrence, and overall survival.Study Design: Retrospective study.Setting: Single institution academic medical center.Methods: Patients diagnosed with oropharyngeal squamous cell carcinoma (OPSCC) between 2007 and 2022 at our institution were included in this study. The Area Deprivation Index (ADI) was used to quantify neighborhood‐level disadvantage based on patients’ primary residence at the time of their diagnosis. Continuous variables were compared between groups using the Wilcoxon rank sum test. For categorical variables, proportions were compared using Fisher's exact test. Overall survival (OS) and recurrence‐free survival (RFS) distributions were estimated using the Kaplan‐Meier method and log‐rank test. OS and RFS were further assessed by univariable and multivariable analyses performed using the Cox proportional hazards model.Results: The higher ADI (more disadvantaged) group consisted of a significantly greater proportion of Black race (P < .001), 10+ pack‐year smoking history (P = .003), and Medicare patients (P = .018). On logistic regression analysis, neither ADI nor other social factors were significantly associated with increased likelihood of advanced clinical staging in the p16 positive OPSCC population. Furthermore, while ADI did not correspond with significant differences in survival, multivariate cox regression model demonstrated that “Other” insurance type (Medicaid and uninsured) (hazard ratio [HR] = 10.1, P = .008), age at diagnosis (1.10, P < .001), and advanced clinical staging (HR = 3.25, P = .004) were all significantly associated with increased HR of death.Conclusion: While ADI may not be significantly associated with outcomes in HPV‐related OPSCC patients, this study revealed significant sociodemographic and risk factor differences across ADIs, as well as individual factors influencing prognosis. These findings emphasize the need for a comprehensive approach to understanding factors influencing HPV‐related OPSCC incidence and prognosis.

21 January 2025 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
APAsher C. Park
Asher C. Park
TNTheodore V. Nguyen
Theodore V. Nguyen
LCLidek Chou
Lidek Chou
KDKatelyn K. Dilley
Katelyn K. Dilley
ZZZhikai Zhu
Zhikai Zhu
BWBrian J.F. Wong
Brian J.F. Wong